UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tocilizumab in chronic active antibody-mediated rejection: rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study)

Trials, 2024-03, Vol.25 (1), p.213-213, Article 213

2024

Volltextzugriff (PDF)

A randomized, doubleblind, placebo-controlled, study of single-dose rituximab as induction in renal transplantation

Transplantation, 2009-05, Vol.87 (9), p.1325-1329

2009

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled study of single dose rituximab as induction in renal transplantation: a 3-year follow-up

Transplantation, 2012-08, Vol.94 (3), p.e21-e22

2012

Volltextzugriff (PDF)

Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation

Transplant international, 2015-01, Vol.28 (1), p.42-51

2015

Volltextzugriff (PDF)

Incidence of end-stage renal disease among live kidney donors

Transplantation, 2006-12, Vol.82 (12), p.1646-1648

2006

Volltextzugriff (PDF)

Oral and lip cancer in solid organ transplant patients – A cohort study from a Swedish Transplant Centre

Oral oncology, 2015-02, Vol.51 (2), p.146-150

2015

Volltextzugriff (PDF)

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial

Kidney medicine, 2023-01, Vol.5 (1), p.100574-100574, Article 100574

2023

Volltextzugriff (PDF)

Safety and efficacy of eculizumab for the prevention of antibody‐mediated rejection after deceased‐donor kidney transplantation in patients with preformed donor‐specific antibodies

American journal of transplantation, 2019-10, Vol.19 (10), p.2865-2875

2019

Volltextzugriff (PDF)

Safety and efficacy of eculizumab in the prevention of antibody‐mediated rejection in living‐donor kidney transplant recipients requiring desensitization therapy: A randomized trial

American journal of transplantation, 2019-10, Vol.19 (10), p.2876-2888

2019

Volltextzugriff (PDF)

The risk of graft loss 5 years after kidney transplantation is increased if cold ischemia time exceeds 14 hours

Clinical transplantation, 2018-09, Vol.32 (9), p.e13377-n/a

2018

Volltextzugriff (PDF)

Authors' Reply to Letter by van den Hoogen and Hilbrands

Transplantation, 2010, Vol.89 (10), p.1295-1296

2010

Volltextzugriff (PDF)

1985 Tocilizumab in chronic active antibody-mediated rejection: a randomized controlled open-label multi-center trial (INTERCEPT study)

Nephrology, dialysis, transplantation, 2024-05, Vol.39 (Supplement_1)

2024

Volltextzugriff (PDF)

An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation

Transplantation research, 2014-06, Vol.3 (1), p.12-12, Article 12

2014

Volltextzugriff (PDF)

P1657GRAFT- AND PATIENT-SURVIVAL IN TRANSPLANT KIDNEY PATIENTS UNDERGOING TRANSPLANT BIOPSIES

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

More on B-Cell–Depleting Induction Therapy and Acute Cellular Rejection

The New England journal of medicine, 2009-09, Vol.361 (12), p.1214-1216

2009

Volltextzugriff (PDF)

ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment

Xenotransplantation (Københaven), 2006-03, Vol.13 (2), p.148-153

2006

Volltextzugriff (PDF)

Successful Combined Partial Auxiliary Liver and Kidney Transplantation in Highly Sensitized Cross‐Match Positive Recipients

American journal of transplantation, 2007-01, Vol.7 (1), p.130-136

2007

Volltextzugriff (PDF)

Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study

Nephrology, dialysis, transplantation, 2010-06, Vol.25 (6), p.2004-2010

2010

Volltextzugriff (PDF)

Difficult-to-Treat Rejections in Kidney Transplant Recipients: Our Experience with Everolimus-Based Quadruple Maintenance Therapy

Journal of clinical medicine, 2023-10, Vol.12 (20), p.6667

2023

Volltextzugriff (PDF)

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical TrialPlain-Language Summary

Kidney medicine, 2023-01, Vol.5 (1), p.100574

2023

Volltextzugriff (PDF)

What Are We Waiting For? Analyses of Factors Influencing Cold Ischemia Time

Transplantation proceedings, 2010-12, Vol.42 (10), p.4436-4437

2010

Volltextzugriff (PDF)

Pseudoaneurysm of the Hepatic Artery Following Liver Transplantation

Transplantation proceedings, 2006-10, Vol.38 (8), p.2679-2682

2006

Volltextzugriff (PDF)

Graft- and Patient-Survival in Transplant Kidney Patients Undergoing Transplant Biopsies

Nephrology, dialysis, transplantation, 2020, Vol.35, p.1973

2020

Volltextzugriff (PDF)

Early Recurrence of Nephrotic Syndrome (Immunoglobulin M Nephropathy) After Renal Transplantation Successfully Treated With Combinations of Plasma Exchanges, Immunoglobulin, and Rituximab

Transplantation proceedings, 2006-10, Vol.38 (8), p.2659-2660

2006

Volltextzugriff (PDF)

Adult ABO-incompatible liver transplantation, using A2 and B donors

Xenotransplantation (Københaven), 2006-03, Vol.13 (2), p.154-159

2006

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(45)
Berichte
(1)

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Transplantation
(25)
Humans
(23)
Male
(21)
Surgery
(21)
Female
(19)
Immunology
(17)
Middle Aged
(17)
Biological And Medical Sciences
(16)
Kidney Transplantation
(15)
Medicin Och Hälsovetenskap
(14)
Adult
(13)
Medical Sciences
(13)
Medical And Health Sciences
(12)
Graft Survival
(11)
Treatment Outcome
(11)
Aged
(10)
Fundamental And Applied Biological Sciences. Psychology
(9)
Fundamental Immunology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tocilizumab in chronic active antibody-mediated rejection: rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study)

A randomized, doubleblind, placebo-controlled, study of single-dose rituximab as induction in renal transplantation

A randomized, double-blind, placebo-controlled study of single dose rituximab as induction in renal transplantation: a 3-year follow-up

Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation

Incidence of end-stage renal disease among live kidney donors

Oral and lip cancer in solid organ transplant patients – A cohort study from a Swedish Transplant Centre

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial

Safety and efficacy of eculizumab for the prevention of antibody‐mediated rejection after deceased‐donor kidney transplantation in patients with preformed donor‐specific antibodies

Safety and efficacy of eculizumab in the prevention of antibody‐mediated rejection in living‐donor kidney transplant recipients requiring desensitization therapy: A randomized trial

The risk of graft loss 5 years after kidney transplantation is increased if cold ischemia time exceeds 14 hours

Authors' Reply to Letter by van den Hoogen and Hilbrands

1985 Tocilizumab in chronic active antibody-mediated rejection: a randomized controlled open-label multi-center trial (INTERCEPT study)

An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation

P1657GRAFT- AND PATIENT-SURVIVAL IN TRANSPLANT KIDNEY PATIENTS UNDERGOING TRANSPLANT BIOPSIES

More on B-Cell–Depleting Induction Therapy and Acute Cellular Rejection

ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment

Successful Combined Partial Auxiliary Liver and Kidney Transplantation in Highly Sensitized Cross‐Match Positive Recipients

Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study

Difficult-to-Treat Rejections in Kidney Transplant Recipients: Our Experience with Everolimus-Based Quadruple Maintenance Therapy

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical TrialPlain-Language Summary

What Are We Waiting For? Analyses of Factors Influencing Cold Ischemia Time

Pseudoaneurysm of the Hepatic Artery Following Liver Transplantation

Graft- and Patient-Survival in Transplant Kidney Patients Undergoing Transplant Biopsies

Early Recurrence of Nephrotic Syndrome (Immunoglobulin M Nephropathy) After Renal Transplantation Successfully Treated With Combinations of Plasma Exchanges, Immunoglobulin, and Rituximab

Adult ABO-incompatible liver transplantation, using A2 and B donors

Suchergebnisse filtern